Right now, Pharmacia (nyse: PHA - news - people ) and Merck (nyse: MRK - news - people ) rule the arthritis market with Celebrex and Vioxx, which reduce inflammation without causing side effects like ulcers in the stomach or intestine.

FORBES: Next For Novartis: An Arthritis Drug